在心力衰竭患者 (EXIT-HF试验) 的家庭与中心基础的炼治疗:一个务实的随机对照试验
Cristine Schmidt1, Sandra Magalhães2, Priscilla Gois Basilio3
1Surgery and Physiology Department, Faculty of Medicine, University of Porto, Portugal; Research Center in Physical Activity, Health and Leisure, Faculty of Sport, University of Porto, Portugal; Laboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal.
概括
家庭心脏康复 (CR) 对于心力衰竭 (HF) 患者,与中心CR一样有效. 这项研究比较了它们的临床和经济影响,为HF患者的护理提供了见解.
科学领域:
- 心脏病学 心脏病学
- 康复医学 康复医学 康复医学
- 卫生经济学 卫生经济学
背景情况:
- 限定的可访问性和坚持性阻碍了对心力衰竭 (HF) 患者进行传统的以运动为基础的心脏康复 (CR) 的参与.
- 基于家庭的CR计划提供了一个潜在的更容易获得和更具成本效益的替代方案以中心为基础的计划.
- 关于国际家庭CR研究结果对当地人口的适用性的证据仍然不清楚.
研究的目的:
- 为了比较家庭和中心CR干预在HF患者的临床和经济影响.
- 评估通过家庭和中心模型提供的12周综合运动训练计划的有效性.
- 评估二次结果,包括生物标志物,身体健康,生活质量和成本效益.
主要方法:
- 一个单中心,非劣势的实用随机受控试验,涉及120名成年HF患者.
- 患者随机分配为为期12周的中心或家庭CR计划,每周有2次监督炼.
- 运动训练包括耐力和阻力练习的组合,家庭参与者从监督的会议开始.
主要成果:
- 目前正在招募患者,预计到2022年12月收集数据.
- 这项研究是对葡萄牙HF患者的传统与家庭CR计划的首次比较.
- 预计结果将为医疗保健专业人员提供有关HF管理CR策略的信息.
结论:
- 家庭CR可以克服HF患者的可访问性和坚持性障碍.
- 这项研究将提供关于家庭CR的临床有效性和成本效益的关键数据.
- 这些发现将指导心力衰竭管理的优化CR策略的实施.
相关概念视频
01:22Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
01:30Heart Failure VII: Nursing Interventions
90
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
90
01:30Heart Failure V: Medical Management
12
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
12
01:29Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
01:27Heart Failure I: Introduction
14
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
14
01:29Heart Failure II: Pathophysiology
15
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
15